After adjusting for confounding factors, patients with CSU experience worse health outcomes and quality of life than patients with AD or PsO.

The UP-AA clinical program includes 2 studies assessing the safety and efficacy of upadacitinib in adults and adolescent patients with severe alopecia areata.

The majority of patients with skin of color and scalp psoriasis who were treated with guselkumab achieved significant scalp clearance.

President Trump ordered the reinstatement of the Presidential Fitness Test program, which tests children's athletic abilities.

New research suggests that the survival benefits observed with different treatments for advanced melanoma vary according to the site of metastasis.

The FDA is updating opioid safety labels to support treatment decisions based on the latest evidence to reduce misuse.

A growing number of women with chronic inflammatory diseases are continuing to use TNF inhibitors throughout pregnancy.

Adding polygenic scores to early-life body mass index up to age 5 improved body mass index prediction at age 18 years.

More than half of pediatric patients with psoriasis or psoriasiform dermatitis had an anogenital or pharyngeal bacterial infection.

An increase in the population burden of atopic dermatitis was associated with increased levels of environmental pollution and weather extremes.

Results of a systematic review and meta-analysis revealed that JIIMs may negatively impact growth and pubertal development.

Patients with PWS who are treated with hemoporfin-mediated PDT have an increased prevalence of dermatitis and skin barrier damage.